MedPath

Lipholyn

Brand Name: Lipholyn

Generic Name: Amphotericin-B

Active
Registration Number

DRP-14156

Dosage Form

Lyophilized Powder For Injection For I.V

Issuance Date

July 3, 2023

Expiry Date

July 3, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength50 mg
Packaging20 mL Type I Clear Transparent Glass Vial with Gray Bromobutyl Rubber Stopper and Aluminum Flip-Off Seal Cap x 1's (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Amphotericin-BActive
Monograph: amphotericin-b

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform